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On May 27, 2013, the World Health Assembly adopted the 
Comprehensive Mental Health Action Plan 2013–20201 
that has great potential to change the direction of 
mental health in countries around the world in the 
next 8 years. This action plan and the accompanying 
resolution—a ﬁ rst in the history of WHO—represent a 
formal recognition of the importance of mental health 
for WHO’s 194 member states. It is also a commitment 
by all member states to take speciﬁ ed actions to improve 
mental health and to contribute to the attainment of a 
set of agreed global targets. 
The action plan focuses on four key objectives: “to 
strengthen eﬀ ective leadership and governance for 
mental health; provide comprehensive, integrated 
and responsive mental health and social care services 
in community-based settings; implement strategies 
for promotion and prevention in mental health, and; 
strengthen information systems, evidence and research 
for mental health”.1 Building upon earlier work,2–5 
and based upon a consultation process that involved 
135 member states, 60 WHO collaborating centres and 
academic centres, 76 non-governmental organisations 
(NGOs), and 17 other organisations and individual 
experts in the past 12 months, consensus was reached 
on the key actions to be taken with respect to each of 
the four objectives by member states, WHO’s Secretariat, 
and partners. Furthermore, for the ﬁ rst time, speciﬁ c 
and measurable global targets and indicators have been 
agreed upon as a way to monitor implementation, 
progress, and impact. The targets include a 20% increase 
in service coverage for severe mental disorders and a 10% 
reduction of the suicide rate in countries by 2020.
The Comprehensive Mental Health Action Plan 
2013–2020 is testimony to some of the shifts in thinking 
about mental health that have occurred over the past 
few years. Issues that used to be at the periphery are 
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and clinical trials will help researchers to do eﬃ  cacy trials 
in countries that have frequent epidemics. Monitoring 
for epidemiological variations in EV71 will also be crucial 
to determine whether the vaccine has ongoing eﬃ  cacy 
and if any genogroup replacement has occurred. With 
these EV71 vaccine eﬃ  cacy data published only 5 years 
after China made HFMD a notiﬁ able disease in 2008, 
Zhu and colleagues’ work provides an excellent model 
of how to use surveillance data to tackle a disease of 
signiﬁ cant public health importance.
*Nigel W Crawford, Steve M Graham
Department of Paediatrics, University of Melbourne, Melbourne, 
Australia; and Murdoch Children’s Research Institute, Royal 
Children’s Hospital, Melbourne, 3052 VIC, Australia
nigel.crawford@mcri.edu.au 
NWC has acted as chief investigator for studies sponsored by CSL and Merck; all 
payments are paid directly to a fund held by Murdoch Children’s Research 
Institute. SMG declares that he has no conﬂ icts of interest. 
1 Zhu F-C, Meng F-Y, Li J-X, et al. Eﬃ  cacy, safety, and immunology of an 
inactivated alum-adjuvant enterovirus 71 vaccine in children in China: 
a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. 
Lancet 2013; published online May 29. http://dx.doi.org/10.1016/S0140-
6736(13)61049-1.
2 Qiu J. E nterovirus 71 infection: a new threat to global public health? 
Lancet Neurol 2008; 7: 868–69.
3 Xu J, Q ian Y, Wang S, et al. EV71: an emerging infectious disease vaccine 
target in the Far East? Vaccine 2010; 28: 3516–21.
4 Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. 
Virology, epidemiology, pathogenesis, and control of enterovirus 71. 
Lancet Infect Dis 2010; 10: 778–90.
5 Tan X,  Huang X, Zhu S, et al. The persistent circulation of enterovirus 71 in 
People’s Republic of China: causing emerging nationwide epidemics since 
2008. PLoS One 2011; 6: e25662.
6 Lee M-S , Tseng F-C, Wang J-R, Chi C-Y, Chong P, Su I-J. Challenges to 
licensure of enterovirus 71 vaccines. PLoS Negl Trop Dis 2012; 6: e1737.
7 Chinese CDC. National incidence and death cases of notiﬁ able class A or 
class B infectious diseases (2008–10). http://www.chinacdc.cn (accessed 
May 14, 2013). 
8 Seiﬀ  A . Cambodia unravels cause of mystery illness. Lancet 2012; 380: 205.
9 Zhu F-C , Liang Z-L, Li X-L, et al. Immunogenicity and safety of an 
enterovirus 71 vaccine in healthy Chinese children and infants: 
a randomised, double-blind, placebo-controlled phase 2 clinical trial. 
Lancet 2013; 381: 1037–45.
10 Lin T- Y, Kao H-T, Hsieh S-H, et al. Neonatal enterovirus infections: 
emphasis on risk factors of severe and fatal infections. Pediatr Infect Dis J 
2003; 22: 889–95.
11 Marsha ll HS, McIntyre P, Richmond P, et al. Changes in patterns of 
hospitalized children with varicella and of associated varicella genotypes 
following introduction of varicella vaccine in Australia. Pediatr Infect Dis J 
2012; published online Dec 17. DOI:10.1097/INF.0b013e31827e92b7.
12 Donaue r S, Payne DC, Edwards KM, et al. Determining the eﬀ ectiveness of 
the pentavalent rotavirus vaccine against rotavirus hospitalizations and 
emergency department visits using two study designs. Vaccine 2013; 
published online April 12. DOI:10.1016/j.vaccine.2013.03.072. 
13 Burche tt HED, Mounier-Jack S, Griﬃ  ths UK, Mills AJ. National 
decision-making on adopting new vaccines: a systematic review. 
Health Policy Plan 2012; 27 (suppl 2): ii62–76.
Published Online
June 4, 2013
http://dx.doi.org/10.1016/
S0140-6736(13)61139-3
See Comment page 1964
AF
P/
Ge
tt
y 
Im
ag
es
Comment
www.thelancet.com   Vol 381   June 8, 2013 1971
now seen as central to providing an eﬀ ective response 
to mental health problems. The plan highlights the 
importance of protecting and promoting human 
rights and includes a central role for the provision 
of community-based care and support. To ensure a 
comprehensive response to mental health, the plan 
introduces the notion of recovery, and moves away from 
a wholly medical model to address income generation 
and education opportunities, housing and social 
services, and other social determinants of mental health. 
The plan also highlights important actions that need 
to be taken around promotion of mental health and 
prevention of mental disorders, and to strengthen and 
empower civil society, especially organisations of people 
with mental disorders and psychosocial disability, so 
that they can take an active role in policy debates and 
decision-making processes.
Ministries of health will need to take a leadership role 
and WHO will work with them and with international and 
national partners, including civil society, to implement 
the plan. Much of the action outlined in the plan will 
take place within countries, especially in the low-income 
and middle-income groups where needs are high and 
resources inadequate.6 WHO will provide technical 
assistance to countries in line with their particular 
needs, and will draw upon the technical expertise of 
WHO collaborating centres, NGOs, academia, and other 
experts. A set of core indicators is being developed so 
that relevant data can be collected from all countries 
to track national, regional, and global progress, to be 
reported back to the World Health Assembly in 2015, 
2018, and 2021.
At the root of the action plan is a vision of “a world in 
which mental health is valued, promoted and protected, 
mental disorders are prevented and persons aﬀ ected 
by these disorders are able to exercise the full range 
of human rights and to access high quality, culturally-
appropriate health and social care in a timely way to 
promote recovery, all in order to attain the highest 
possible level of health and participate fully in society and 
at work free from stigmatisation and discrimination”.1
Implementation of the action plan will face challenges; 
in particular, years or decades of inadequate investment 
into human and ﬁ nancial resources for mental health 
care need to be quickly reversed. Health policy planners 
and health professionals can help to enable this turn-
around by ensuring that promoting, protecting, and 
restoring good mental health represents an integral part 
of their responsibilities. Local leaderships will need to 
develop to support this process. With concerted action 
by all stakeholders, WHO hopes to overcome these 
challenges and assist countries to deliver health care and 
other services that better conform to WHO’s deﬁ nition 
of health,7 which explicitly recognises the critical place of 
mental and social wellbeing.
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